Australia markets closed

Argent BioPharma Limited (RGT.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.30000.0000 (0.00%)
At close: 03:42PM AEST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
30/06/2023
30/06/2022
30/06/2021
30/06/2020
30/06/2019
Cash flows from investing activities
Investments in property, plant and equipment
-2,693
-189.871
-2,693
-3,327
-962.097
-
Acquisitions, net
-155.971
-
-155.971
-479.687
-13.252
-
Purchases of investments
-155.971
-
-
-
-
-
Sales/maturities of investments
-
-
-
302.823
-
-
Other investing activities
1,586
796.066
1,586
-546.995
-
-
Net cash used for investing activities
-1,111
606.195
-1,111
-1,494
-969.884
-
Cash flows from financing activities
Debt repayment
61.424
216.338
61.424
-
-
-
Common stock issued
10,703
3,087
10,703
12,760
11,433
-
Common stock repurchased
-321.684
-317.838
-764.061
-1,203
-
-8.948
Other financing activities
-263.008
-200.955
-263.008
-255.993
-971.288
-
Net cash used provided by (used for) financing activities
9,738
9,732
9,738
17,051
10,462
-
Net change in cash
-3,532
-1,656
-3,532
3,568
-464.846
-
Cash at beginning of period
5,433
1,886
5,433
1,873
2,354
-
Cash at end of period
1,886
239.821
1,886
5,433
1,873
-
Free cash flow
Capital expenditure
-2,693
-189.871
-2,693
-3,327
-962.097
-
Free cash flow
-14,851
-12,185
-14,851
-15,317
-10,919
-